Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease
Authors:
- Anila DuniADAnila Duni
- Athanasios KitsosAKAthanasios Kitsos
- Aris BechlioulisABAris Bechlioulis
- Georgios S. MarkopoulosGeorgios S. Markopoulos
- Lampros LakkasLLLampros Lakkas
- Gerasimos BaxevanosGBGerasimos Baxevanos
- Michail MitsisMMMichail Mitsis
- George VartholomatosGVGeorge Vartholomatos
- Katerina K. NakaKNKaterina K. Naka
- Evangelia DounousiEDEvangelia Dounousi
Open Access
- 27 March 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1029
Abstract
Maladaptive activation of the immune system plays a key role in the pathogenesis of chronic kidney disease (CKD). Our aim was to investigate differences in circulating immune cells between type 2 cardiorenal syndrome (CRS-2) patients and CKD patients without cardiovascular disease (CVD). CRS-2 patients were prospectively followed up, with the primary endpoint being all-cause and cardiovascular mortality. Method: A total of 39 stable males with CRS-2 and 24 male CKD patients matched for eGFR (CKD-EPI) were enrolled. A selected panel of immune cell subsets was measured by flow cytometry. Results: Compared to CKD patients, CRS-2 patients displayed higher levels of proinflammatory CD14++CD16+ monocytes (p = 0.04) and T regulatory cells (Tregs) (p = 0.03), lower lymphocytes (p = 0.04), and lower natural killer cells (p = 0.001). Decreased lymphocytes, T-lymphocytes, CD4+ T-cells, CD8+ T-cells, Tregs, and increased CD14++CD16+ monocytes were associated with mortality at a median follow-up of 30 months (p < 0.05 for all). In a multivariate model including all six immune cell subsets, only CD4+ T-lymphocytes remained independent predictors of mortality (OR 0.66; 95% CI 0.50–0.87; p = 0.004). Conclusion: Patients with CRS-2 exhibit alterations in immune cell profile compared to CKD patients of similar kidney function but without CVD. In the CRS-2 cohort, CD4+ T-lymphocytes independently predicted fatal cardiovascular events.Keywords
This publication has 48 references indexed in Scilit:
- Changes in the Monocytic Subsets CD14dimCD16+and CD14++CD16−in Chronic Systolic Heart Failure PatientsMediators of Inflammation, 2012
- Predictive Value of Low Relative Lymphocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection FractionCirculation: Heart Failure, 2012
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection FractionCirculation: Heart Failure, 2011
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality InitiativeEuropean Heart Journal, 2009
- Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expressionNephrology Dialysis Transplantation, 2009
- Aspects of Immune Dysfunction in End-stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2008
- Proinflammatory CD14+CD16+ Monocytes Are Associated With Subclinical Atherosclerosis in Renal Transplant PatientsAmerican Journal of Transplantation, 2008
- Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patientsNephrology Dialysis Transplantation, 2007
- Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspectiveKidney International, 2006
- Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failureThe American Journal of Cardiology, 2004